Adaptive Ketogenic–Mediterranean Protocol (AKMP) in Real Clinical Practice: 14-Week Pre–Post Cohort Study on Glucolipid Markers and Safety
Nutrients · 2025
DOI: 10.3390/nu17223559 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nutrients, 2025. Verfasst von Cayetano García-Gorrita und 3 weiteren Autor:innen. Beteiligte Einrichtung: Food & Health Lab, Institute of Materials Science, University of Valencia, 46980 Paterna, Spain. Hauptthemen laut MEDLINE: Diet, Ketogenic, Lipids, Overweight, Obesity. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Overweight and obesity are associated with insulin resistance, atherogenic dyslipidemia, and low-grade inflammation. We evaluated analytical safety and within-person metabolic changes under the Adaptive Ketogenic–Mediterranean Protocol (AKMP) in real-world practice.
Methods
Single arm, prospective pre–post cohort. We enrolled 112 adults; 105 completed 14 weeks of AKMP (12 in nutritional ketosis ≤ 20 g carbohydrate/day + 2 of gradual reintroduction). Fasting venous samples were analyzed in accredited laboratories (glycolipid profile, hepatic–renal function, inflammatory markers; insulin, thyroid hormones, cortisol). HOMA-IR, TyG, and remnant cholesterol (RC) were calculated; body composition was measured by segmental bioimpedance. Paired analyses were used, with hierarchical gatekeeping for the conditional co-primary outcome and prespecified Δ~Δ correlations.
Results
HOMA-IR −52.8% (Δ −1.80; p < 0.001) and RC −35.1% (Δ −10.64 mg/dL; p < 0.001); fasting glucose −13.7 mg/dL, insulin −5.9 μU/L; TyG −0.23 and TG/HDL-c −1.21 (all p < 0.001). Lipids: TG −35.1% and LDL-c −11.2%; HDL-c remained stable. Anthropometry: weight −14.85 kg (−14.7%) and trunk fat −4.88 kg (−22.2%) (p < 0.001). Safety: no serious adverse events; GGT −47.0%, eGFR +11.0%, and CRP −24.6% (p < 0.001). Prespecified correlations supported the internal consistency of the glycolipid axis (e.g., ΔHOMA-IR~ΔTyG; ΔRC~ΔHOMA-IR).
Conclusions
In adults with overweight or obesity, the AKMP was associated with improvements in the glucose–insulin axis, atherogenic profile (RC, TG/HDL-c, TG), and body composition, while maintaining a favorable safety profile. The protocol appears feasible in clinical practice and monitorable with routine laboratory tests, although randomized controlled trials are needed to confirm causality and long-term sustainability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Food & Health Lab, Institute of Materials Science, University of Valencia, 46980 Paterna, Spain.
- NUTRALiSS Research Group, Faculty of Health Sciences, Universitat Oberta de Catalunya, Rambla del Poblenou 156, 08018 Barcelona, Spain.
- Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia-Health Research Institute La Fe, 46026 Valencia, Spain.
- Department of Medicine, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
- Department of Endocrinology and Nutrition, University and Polytechnic Hospital La Fe, 46026 Valencia, Spain.
ORCID-Profile: Cayetano García-Gorrita, Nadia San Onofre, Juan F Merino-Torres, Jose M Soriano
Zitieren
APA
García-Gorrita, C., San Onofre, N., Merino-Torres, J. F., & Soriano, J. M. (2025). Adaptive Ketogenic–Mediterranean Protocol (AKMP) in Real Clinical Practice: 14-Week Pre–Post Cohort Study on Glucolipid Markers and Safety. Nutrients. https://doi.org/10.3390/nu17223559
Vancouver
García-Gorrita C, San Onofre N, Merino-Torres JF, Soriano JM. Adaptive Ketogenic–Mediterranean Protocol (AKMP) in Real Clinical Practice: 14-Week Pre–Post Cohort Study on Glucolipid Markers and Safety. Nutrients. 2025. doi:10.3390/nu17223559
BibTeX
@article{GarcaGorrita2025,
author = {García-Gorrita, Cayetano and San Onofre, Nadia and Merino-Torres, Juan F and Soriano, Jose M},
title = {Adaptive Ketogenic–Mediterranean Protocol (AKMP) in Real Clinical Practice: 14-Week Pre–Post Cohort Study on Glucolipid Markers and Safety},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17223559}
}
EUVIMED